These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 12891558)
1. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Yamamoto H; Kondo M; Nakamori S; Nagano H; Wakasa K; Sugita Y; Chang-De J; Kobayashi S; Damdinsuren B; Dono K; Umeshita K; Sekimoto M; Sakon M; Matsuura N; Monden M Gastroenterology; 2003 Aug; 125(2):556-71. PubMed ID: 12891558 [TBL] [Abstract][Full Text] [Related]
2. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats. Wei M; Morimura K; Wanibuchi H; Shen J; Salim EI; Moku M; Hakoi K; Fukushima S Int J Cancer; 2005 Jan; 113(3):354-8. PubMed ID: 15455344 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide. Denda A; Kitayama W; Murata A; Kishida H; Sasaki Y; Kusuoka O; Tsujiuchi T; Tsutsumi M; Nakae D; Takagi H; Konishi Y Carcinogenesis; 2002 Feb; 23(2):245-56. PubMed ID: 11872629 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Wei M; Morimura K; Wanibuchi H; Shen J; Doi K; Mitsuhashi M; Moku M; Salim EI; Fukushima S Cancer Lett; 2003 Dec; 202(1):11-6. PubMed ID: 14643021 [TBL] [Abstract][Full Text] [Related]
5. Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats. Niki H; Yamada M; Yamaki K; Mue S; Ohuchi K Eur J Pharmacol; 1998 Mar; 344(2-3):261-7. PubMed ID: 9600662 [TBL] [Abstract][Full Text] [Related]
6. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187 [TBL] [Abstract][Full Text] [Related]
7. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Sakaida I; Matsumura Y; Akiyama S; Hayashi K; Ishige A; Okita K J Hepatol; 1998 Feb; 28(2):298-306. PubMed ID: 9514543 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Denda A; Endoh T; Kitayama W; Tang Q; Noguchi O; Kobayashi Y; Akai H; Okajima E; Tsujiuchi T; Tsutsumi M; Nakae D; Konishi Y Carcinogenesis; 1997 Oct; 18(10):1921-30. PubMed ID: 9364001 [TBL] [Abstract][Full Text] [Related]
10. Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor, and p-bromophenacylbromide, a phospholipase A2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. Endoh T; Tang Q; Denda A; Noguchi O; Kobayashi E; Tamura K; Horiguchi K; Ogasawara H; Tsujiuchi T; Nakae D; Sugimura M; Konishi Y Carcinogenesis; 1996 Mar; 17(3):467-75. PubMed ID: 8631132 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer. Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Uefuji K; Ichikura T; Shinomiya N; Mochizuki H Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258 [TBL] [Abstract][Full Text] [Related]
13. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. Wakitani K; Nanayama T; Masaki M; Matsushita M Jpn J Pharmacol; 1998 Nov; 78(3):365-71. PubMed ID: 9869271 [TBL] [Abstract][Full Text] [Related]
14. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [TBL] [Abstract][Full Text] [Related]
15. Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats. Denda A; Endoh T; Tang Q; Tsujiuchi T; Nakae D; Konishi Y Mutat Res; 1998 Jun; 402(1-2):279-88. PubMed ID: 9675312 [TBL] [Abstract][Full Text] [Related]
16. JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues. Wakitani K; Tazaki H; Matsushita M; Iwamura H Inflamm Res; 2000 Mar; 49(3):117-22. PubMed ID: 10807499 [TBL] [Abstract][Full Text] [Related]
17. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Hida T; Kozaki K; Ito H; Miyaishi O; Tatematsu Y; Suzuki T; Matsuo K; Sugiura T; Ogawa M; Takahashi T; Takahashi T Clin Cancer Res; 2002 Jul; 8(7):2443-7. PubMed ID: 12114451 [TBL] [Abstract][Full Text] [Related]
18. Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats. Nagahara T; Okano J; Fujise Y; Abe R; Murawaki Y Biomed Pharmacother; 2010 May; 64(5):319-26. PubMed ID: 20434301 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722 [TBL] [Abstract][Full Text] [Related]
20. Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats. Sakaida I; Hironaka K; Uchida K; Okita K Dig Dis Sci; 1999 Mar; 44(3):560-9. PubMed ID: 10080151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]